Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1993-5-18
|
pubmed:abstractText |
The gastrointestinal tumour cell lines, MKN45G and C146 possessed oestrogen receptors (ER) of affinities 1.8 x 10(-8) and 5.2 x 10(-9) M respectively. C146 and MKN45G had enhanced proliferation in the presence of oestradiol (10(-8) and 10(-10) M). Fifty-six percent (5/9) of primary gastric and colorectal tumours had their proliferation enhanced by oestradiol. The anti-steroidal drug, danazol, inhibited the basal growth of MKN45G (10 micrograms ml-1 45% of the untreated control), C146 (10 and 5 micrograms ml-1, 20 and 48% of control, respectively) and 3/9 GI primary tumours (10 micrograms ml-1). Danazol competed with 3 [H]-Oestradiol for binding to ER on MKN45G and C146, at concentrations from 10 to 1 micrograms ml-1.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0250-7005
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
13
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
97-102
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8476232-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:8476232-Breast Neoplasms,
pubmed-meshheading:8476232-Cell Division,
pubmed-meshheading:8476232-Danazol,
pubmed-meshheading:8476232-Drug Interactions,
pubmed-meshheading:8476232-Estradiol,
pubmed-meshheading:8476232-Gastrointestinal Neoplasms,
pubmed-meshheading:8476232-Humans,
pubmed-meshheading:8476232-Kinetics,
pubmed-meshheading:8476232-Neoplasms, Hormone-Dependent,
pubmed-meshheading:8476232-Receptors, Estrogen,
pubmed-meshheading:8476232-Tritium
|
pubmed:articleTitle |
Interactions between oestradiol and danazol on the growth of gastrointestinal tumour cells.
|
pubmed:affiliation |
Cancer Research Campaign Laboratories, University of Nottingham, U.K.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|